Searched for
MD NILESH GUPTA
US-Iran peace deal: Is it enough to end the 2-year drought for Nifty bulls, bring FIIs back?A US-Iran peace framework has sparked a sharp rally in Indian markets, sending crude oil prices lower, strengthening the rupee and promptin...- ET Alpha Wealth Summit: Future-proofing portfolios for the next decadeIndia's leading investment minds will converge at the ET Alpha Wealth Summit in Mumbai on June 4 to address market uncertainty and identify...
- Heatwave spurs surge in AC, beverage, ice cream output in IndiaSoaring temperatures have triggered a sharp demand rebound for ACs, beverages, and ice cream, with companies boosting output after a 50% sa...
- Lupin receives USFDA EIR for Goa facility with VAI statusDrug maker Lupin said it has received an Establishment Inspection Report from the US Food and Drug Administration for its Goa-based manufac...
- Lupin appoints Christoph Funke as new CTOFunke has previously worked in leadership roles at organisations such as Fresenius Kabi and Strides Pharma Science."In his leadership roles...
- Lupin says USFDA warning on Goa and Pithampur facilities are resolvedLupin on Thursday said it has received correspondence from the USFDA that it has now addressed the concerns raised in the Warning Letter fo...
- A Balasubramanian re-elected as chairperson, Radhika Gupta elected vice-chairperson of AMFIAs the Chairman of AMFI, A Balasubramanian would also continue as the ex-officio Chairman of AMFI Financial Literacy Committee till the con...
- Lupin announces USFDA acceptance for a biosimilar applicationThe pegfilgrastim filing is the company's first biosimilar filing in the US and is a milestone in the drug maker's research and innovation ...
- Over 158 applications for generic products pending with USFDA for approval: LupinSharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last ...
- Lupin gets 5 observations from USFDA for its Vizag facilityThe inspection of company's Vizag API manufacturing facility by the United States Food and Drug Administration (USFDA) has been completed, ...
- Lupin gets 2 observations from USFDA for Nagpur facility"The inspection closed with two 483 observations," Lupin said.
- Lupin sells Japanese arm Kyowa for $300 millionLupin MD Nilesh Gupta said the company made 4½ x the initial investment it made in Japan.
- Lupin gets EIR from USFDA for its Nagpur facilityUSFDA gives EIR on closure of inspection of an establishment that is the subject of an FDA or FDA-contracted inspection.
- Lupin gets EIR from USFDA for Nagpur facilityCommenting on the development, Lupin MD Nilesh Gupta said, "The successful completion of the Nagpur facility inspection is a positive devel...
- Lupin gets EDQM nod for its Mandideep facilityThe inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for...
- Market and business will be as usual in spite of GST: Nilesh Gupta, MD, Vijay Sales"The June pricing was once in a life thing, until GST 2 comes in, in the next two three years something like that it will never come again"...
- Lupin founder DB Gupta, a self made maverick who wanted to take out TB in India, deadGupta is survived by wife and five children (four daughters and a son) Vinita Gupta, the eldest daughter and Nilesh Gupta were handed over ...
- Expect this Diwali sale to be the best in last 3-4 years: Nilesh Gupta, MD of Vijay SalesNilesh Gupta said, "till last year, people were buying but they were trying to tone down their budget and buy less, now they are buying the...
- Interaction with USFDA very positive and forthcoming: Nilesh Gupta, Lupin"I think the approvals are definitely on the uptick. Inspections are a reality of life."
- Lupin Q4 net surges nearly three-fold to Rs 408 croreThe net profit of the drug major jumped to Rs 408 crore for the fourth quarter ended March 2013 against Rs 155 crore in the same period pre...
Load More
